VACCINATION OF CLL PATIENTS WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC BODIES (APO-DC): A PHASE I-II CLINICAL TRIAL

被引：0
|
作者：
Palma, M. [1 ]
Hansson, L. [2 ]
Adamson, L. [1 ]
Eriksson, I. [1 ]
Nasman-Glaser, B. [1 ]
Widen, K. [1 ]
Choudhury, A. R. [1 ]
Osterborg, A. [2 ]
Mellstedt, H. [3 ]
机构：
[1] Karolinska Inst, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [31] Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma.
    Ridolfi, Laura
    Gurrieri, Lorena
    Riva, Nada
    Bulgarelli, Jenny
    De Rosa, Francesco
    Guidoboni, Massimo
    Fausti, Valentina
    Ranallo, Nicoletta
    Tazzari, Marcella
    Petrini, Massimiliano
    Granato, Anna Maria
    Pancisi, Elena
    Foca, Flavia
    Dall'Agata, Monia
    Amadori, Elena
    Cortesi, Pietro
    Gamboni, Alessandro
    Pasini, Giuseppe
    Ibrahim, Toni
    Tosatto, Luigino
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a phase I clinical trial.
    Fuessel, S
    Meye, A
    Schmitz, M
    Zastrow, S
    Linné, C
    Richter, K
    Hakenberg, OW
    Rieber, EP
    Wirth, MP
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9120S - 9120S
  • [33] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial.
    Meye, A.
    Fuessel, S.
    Schmitz, M.
    Zastrow, S.
    Linne, C.
    Richter, K.
    Lobel, B.
    Hakenberg, O. W.
    Hoelig, K.
    Rieber, P. E.
    Wirth, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 112S - 112S
  • [34] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Immunological results of a phase I clinical trial
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 162 - 162
  • [35] Clinical results of a Phase I/II trial of adjuvant therapeutic vaccination in high risk resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and survivin
    Tryggestad, Anne Merete Aa.
    Axcrona, Karol
    Bigalke, Iris
    Inderberg-Suso, Else M.
    Skorstad, Gjertrud
    Axcrona, Ulrika
    Aamdal, Steinar
    Gaudernack, Gustav
    Schendel, Dolores
    Lilleby, Wolfgang
    Dueland, Svein
    Kvalheim, Gunnar
    CANCER RESEARCH, 2016, 76
  • [36] Pilot phase I/II clinical trial with autologous mesenchymal stem cells in patients with multiple sclerosis
    Karussis, D.
    Slavin, S.
    Karageorgiou, C.
    Kassis, I.
    Vaknin-Dembinski, A.
    Petrou, P.
    Gomori, J.
    Gowda-Kurkalli, B.
    Ben-Hur, T.
    Bulte, J.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1436 - 1436
  • [37] A phase I clinical trial in patients with newly diagnosed glioblastoma vaccinated with autologous dendritic cells pulsed with autologous tumor lysate.
    Boynton, A. L.
    Prins, R.
    Bosch, M.
    Yang, M.
    Odesa, S. K.
    Khan-Farooqi, H.
    Cloughesy, T.
    Liau, L.
    CYTOTHERAPY, 2006, 8
  • [38] Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    Juan Hernando
    Tjoung-Won Park
    Kirsten Kübler
    Ruth Offergeld
    Harald Schlebusch
    Thomas Bauknecht
    Cancer Immunology, Immunotherapy, 2002, 51 : 45 - 52
  • [39] Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies:: clinical and immunological evaluation of a phase I trial
    Hernando, JJ
    Park, TW
    Kübler, K
    Offergeld, R
    Schlebusch, H
    Bauknecht, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (01) : 45 - 52
  • [40] A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients
    Chevallier, Patrice
    Saiagh, Soraya
    Dehame, Virginie
    Guillaume, Thierry
    Peterlin, Pierre
    Bercegeay, Sylvain
    Le Bris, Yannick
    Bossard, Celine
    Gauvrit, Isabelle
    Dreno, Brigitte
    Juge-Morineau, Nadine
    Bene, Marie C.
    Gregoire, Marc
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (10) : 3511 - 3514
12345